BSX
Boston Scientific Corp
Boston Scientific Corp historical holders
total: 8
Polen Capital Management Boston Scientific Corp transactions over time
- Total transactions:
- 3
- New positions:
- 1
- Reduced:
- 2
- Held since:
- 2025 Q3
- Held for:
- 3 quarters
- Latest activity:
- 2026 Q1
Polen Capital Management has been an institutional investor in Boston Scientific Corp (BSX) since 2025 Q3. According to 2026 Q1 report, Polen Capital Management holds 579,739 shares with a market value of roughly $36.38M representing 0.25% of their equity portfolio. The fund/company first acquired BSX in 2025 Q3, initially purchasing about 5.60M shares. Since the initial investment, Polen Capital Management has made 2 more transactions in this position.
Does Polen Capital Management still hold BSX?
Yes, Polen Capital Management continues to hold Boston Scientific Corp (BSX). According to their 2026 Q1 report, they maintain a position of 579,739 shares valued at approximately $36.38M, representing 0.25% of their equity portfolio.
When did Polen Capital Management first invest in BSX?
Polen Capital Management first invested in Boston Scientific Corp (BSX) in 2025 Q3 at the reported quarter-end price of $97.63 per share, acquiring 5,598,286 shares in their initial purchase.
What is Polen Capital Management's average cost basis for BSX?
Based on historical transaction data, Polen Capital Management's estimated cost basis for Boston Scientific Corp (BSX) is approximately $97.63 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $97.63
- Weighted AVG sell price:
- $73.00
BSX transactions history by Polen Capital Management
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.25%
|
579,739
|
$62.75
|
$36,378,606
|
-85.58% (-3,439,813)
|
-0.92%
|
|
2025 Q4
|
1.64%
|
4,019,552
|
$95.35
|
$383,264,286
|
-28.20% (-1,578,734)
|
-0.49%
|
|
2025 Q3
|
1.77%
|
5,598,286
|
$97.63
|
$546,560,636
|
new
|
+1.77%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.